Test Price
2,800 AED✅ Home Collection Available
DOK7 Gene Myasthenic Syndrome, Congenital, Type 10 Genetic Test in UAE | 2,800 AED | 2026 DHA Guidelines
تحليل جين DOK7 لمتلازمة الوهن العضلي الخلقي من النوع العاشر في الإمارات | 2,800 درهم إماراتي | معتمد من هيئة الصحة بدبي
Executive Summary
- ✓ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing.
- ✓ Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain & VIP Mobile Phlebotomy (8 AM – 11 PM).
- ✓ Clinical Guidance: Telephonic Post-Test Clinical Guidance in Result Interpretation by DHA-Licensed Specialists.
- ✓ Insurance: Direct Billing Verification & Pre-Authorization via WhatsApp +971 54 548 8731.
الملخص التنفيذي: فحص دقيق لتحديد الطفرات في جين DOK7 باستخدام تسلسل متطور، مع خدمة سحب منزلي آمن واستشارة طبية هاتفية بعد النتيجة، وتغطية تأمينية مباشرة.
Clinical Test Overview
The DOK7 Gene Genetic Test screens for pathogenic variants in the DOK7 gene responsible for Congenital Myasthenic Syndrome Type 10 (CMS10), a rare neuromuscular junction disorder characterized by fatigable limb-girdle weakness and respiratory involvement. This test uses high-coverage Next-Generation Sequencing to detect point mutations, small indels, and copy number changes, enabling definitive diagnosis, carrier identification, and prenatal risk assessment. يفحص تحليل جين DOK7 الطفرات الوراثية المرتبطة بالوهن العضلي الخلقي من النوع العاشر؛ وهو فحص حساس يناسب التشخيص لحاملي الأعراض أو التاريخ العائلي.
| Feature | Our DOK7 NGS Test | Closest Alternative (Multi-Gene Panel) |
|---|---|---|
| Precision | 99.9% diagnostic sensitivity, full gene sequencing | ~95% sensitivity, may miss deep intronic or novel exon variants |
| Methodology | Next-Generation Sequencing (Illumina, 300x coverage) | Targeted NGS panel with exon-only analysis |
| Speed (TAT) | 3–4 Weeks | 4–6 Weeks |
| Cost | 2,800 AED | 2,500–3,200 AED |
Physician Insight & Safety Protocol
“Genetic test results must always be clinically correlated by a neurologist or medical geneticist. A negative report does not rule out other neuromuscular disorders, and I strongly advise patients not to interpret results in isolation. This test is a powerful diagnostic tool that, when integrated with EMG, antibody panels, and clinical history, leads to precise management.”
– Dr. Prabhakar Reddy, DHA License No. 61713011, Consultant Neurologist & Clinical Geneticist
⚠️ Medication & Clinical Warning
Do not discontinue prescribed medication (e.g., pyridostigmine, 3,4-DAP, immunosuppressants) without direct instruction from your treating physician. Abrupt changes may precipitate severe respiratory crisis or aspiration. Always consult your neurologist before a scheduled test.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Inability to provide informed consent (minors require legal guardian consent per CDS Law 2026); active bleeding disorder or severe anemia; acute unstable illness requiring hospitalization.
- Post-Phlebotomy Red Flags: Rapid onset of severe muscle weakness, double vision, drooping eyelids, or difficulty breathing within 24 hours – seek emergency medical evaluation immediately.
- Genetic Counseling Note: A pre-test genetic counseling session is mandatory; a pedigree chart of affected family members will be drawn to interpret variants accurately.
UAE Regulatory & Data Privacy Compliance
This test is performed in strict accordance with Federal Decree-Law No. 41 of 2024 (Art. 87) on medical testing, CDS Law 2026 for minor genetic testing, and UAE PDPL (Federal Decree-Law No. 45 of 2021) for genetic data privacy. All results are encrypted and stored on UAE-based secure servers. The laboratory holds ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139) and DHA Facility License No. 9834453.
Patient FAQ & Clinical Guidance
1. Who should consider the DOK7 Genetic Test?
The is indicated for individuals with early-onset limb-girdle muscle weakness, ptosis, or respiratory symptoms suggesting congenital myasthenic syndrome, or for asymptomatic family members seeking carrier status. It also aids reproductive planning when one parent is known to carry a DOK7 mutation.
يُنصح بهذا التحليل للأفراد الذين يعانون ضعفاً عضلياً في الأطراف أو أعراض تنفسية مبكرة؛ وللأقارب حاملي الطفرة لتقييم الخطر.
2. What does the 2800 AED price include?
The fee covers full gene sequencing, bioinformatic analysis, digital results report, telephonic clinical guidance, and home sample collection across all UAE emirates. Insurance direct billing is available for eligible policies; our WhatsApp team verifies coverage before collection.
يشمل السعر التسلسل الكامل، التحليل المعلوماتي، التقرير الرقمي، الاستشارة الهاتفية، وسحب العينة المنزلي في جميع أنحاء الإمارات؛ مع خيار الفوترة التأمينية المباشرة.
3. How is sample collection performed and what preparation is needed?
A certified phlebotomist visits your location (8 AM–11 PM) to draw 4 mL of whole blood or collect a dried blood spot; no fasting or medication adjustment is required unless directed. A genetic counseling session by video call is arranged before the collection to create a pedigree chart.
يتم السحب بواسطة ممرض معتمد في المنزل، ولا يتطلب صياماً؛ مع جلسة استشارة وراثية قبل الفحص لوضع مخطط النسب العائلي.
Insurance Enquiries & Appointment Scheduling
Direct Billing Verification via WhatsApp
WhatsApp +971 54 548 8731ISO 9001:2015 | DHA Facility 9834453 | 2023–2026 UAE Medical Testing Regulations
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians